PSM
Muhammad Talha Waheed, MD
Research Fellow
Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA
Duarte, California, United States
Muhammad Talha Waheed, MD
Research Fellow
Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA
Duarte, California, United States
Muhammad Talha Waheed, MD
Research Fellow
Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA
Duarte, California, United States
Vahan Kepenekian, MD
Surgical Oncologist
Department of Digestive Surgery, CHU Lyon Sud, Pierre-Benite, France, United States
Isabelle Sourrouille, MD
Surgical Oncologist
Department of Surgical Oncology, Institut Gustav Roussy, Paris, France, United States
Frédéric Dumont, MD, PhD
Surgical Oncologist
Department of Surgical Oncology, Institut du Cancer Ouest, Nantes, France, United States
Marc Pocard, MD, PhD
Professor
Department of Digestive Surgery, CHU Pitié Salpêtriere, Paris, France, United States
Anai Kothari, MD, MS
Assistant Professor
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Charles A. Staley, MD
Professor
Division of Surgical Oncology, Emory University, Atlanta, GA, United States
Atlanta, GA, United States
Clarisse Eveno, MD, PhD
Professor
Department of Digestive Surgery, CHU Claude Huriez, Lille, France, United States
Sameer H. Patel, MD, FSSO (he/him/his)
Associate Professor
Division of Surgical Oncology, University of Cincinnati, Cincinnati, OH, United States, United States
Jordan M. Cloyd, MD
Surgical Oncologist
Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, United States
Columbus, Ohio, United States
Laura A. Lambert, MD
Professor
Division of Surgical Oncology, University of Utah, Salt Lake City, UT, United States
Salt Lake City, Utah, United States
Martin Hübner, MD
Professor
Department of Digestive Surgery, CHUV, Lausanne, Switzerland, United States
Fabian M. Johnston, MD, MHS
Associate Professor of Surgery
Division of Gastrointestinal Surgical Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States
Baltimore, Maryland, United States
Patrick R. Varley, MD, MS
Assistant Professor
Division of Surgical Oncology, School of Medicine and Public Health, University of Wisconsin–Madison, Madison, WI, USA, United States
Keith F. Fournier, MD
Associate Professor
Division of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, United States, United States
Sean Dineen, MD
Assistant Professor
Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States
Tampa, Florida, United States
Travis E. Grotz, MD
Associate Professor
Mayo Clinic, Rochester, MN, United States
Rochester, Minnesota, United States
Lana Bijelic, MD
Chief Peritoneal Surface Malignancies Unit
Department of Surgical Oncology, CHU Moises Broggi, Barcelona, Spain, United States
Olivia Sgarbura, MD, PhD
Surgical Oncologist
Department of Surgical Oncology, Institut du Cancer Montpellier, Montpellier, France
Montpellier, United States
Mustafa Raoof, MD, MS
Assistant Professor
Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA
Duarte, California, United States
This is the largest comparative analysis of RFS/P-RFS vs OS after curative-intent cytoreduction. Both RFS and P-RFS can be used as surrogate endpoints for OS in CRC-PM efficacy trials. Compared to RFS, P-RFS appears to be a better surrogate for OS.